Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Insights into sepsis therapeutic design based on the apoptotic death pathway Hattori Y; Takano K; Teramae H; Yamamoto S; Yokoo H; Matsuda NJ Pharmacol Sci 2010[]; 114 (4): 354-65Sepsis remains the leading cause of death in critically ill patients. A major problem contributing to sepsis-related high mortality is the lack of effective medical treatment. Thus, the key goal in critical care medicine is to develop novel therapeutic strategies that will impact favorably on septic patient outcome. While it is generally accepted that sepsis is an inflammatory state resulting from the systemic response to infection, apoptosis is implicated to be an important mechanism of the death of lymphocytes, gastrointestinal and lung epithelial cells, and vascular endothelial cells associated with the development of multiple organ failure in sepsis. The pivotal role of cell apoptosis is now highlighted by multiple studies demonstrating that prevention of cell apoptosis can improve survival in clinically relevant animal models of sepsis. In this review article, we address the scientific rationale for remedying apoptotic cell death in sepsis and propose that therapeutic efforts aimed at blocking cell signaling pathways leading to apoptosis may represent an attractive target for sepsis therapy.|*Molecular Targeted Therapy[MESH]|Animals[MESH]|Apoptosis/drug effects/*physiology[MESH]|Caspase Inhibitors[MESH]|Caspases/genetics/physiology[MESH]|Endothelial Cells/pathology[MESH]|Enzyme Inhibitors/pharmacology/therapeutic use[MESH]|Epithelial Cells/pathology[MESH]|Gene Silencing[MESH]|Glucocorticoids/administration & dosage/adverse effects/pharmacology[MESH]|Humans[MESH]|Lymphocytes/pathology[MESH]|RNA, Small Interfering/therapeutic use[MESH]|Sepsis/*etiology/*therapy[MESH]|Signal Transduction/drug effects/*physiology[MESH] |